Linda Lee, PharmD.

Vice President, Clinical Science

Linda is a biotechnology professional with experience spanning both clinical oncology research and industry drug development with a career focused on advancing innovative cancer therapies for patients. Prior to joining Volastra, Linda worked at I-Mab Biopharma in early phase development for all their global immuno-oncology assets in both solid tumors and hematological malignancies. Prior to entering industry, Linda spent most of her career in the clinic at Dana Farber Cancer Institute and Yale Cancer Center where she was involved with early-stage oncology drug development and clinical research. She received her PharmD from the Massachusetts College of Pharmacy and Health Sciences.